Curium International
0860.215.596 · rovalta.com · 25/09/2026
Curium International
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOCurium International is a Public limited company incorporated in 2003. Its main activity is: Engineering activities and related technical consultancy. Its registered office is in Bruxelles.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0860.215.596
- Incorporation
- 22/08/2003
- Legal form
- Public limited company
- Registered office
- Boulevard Bischoffsheim 39 box 4
1000 Bruxelles · BruxellesSee on map - Contributed capital
- 21 499 761,61 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 218
Financials
Source · NBB, 22 filingsTrend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 3,5 M € | +6.5% | 3,2 M € | -10.7% | 3,6 M € | +7.8% | 3,4 M € | +37.9% | 2,4 M € |
| EBITDA | -55,3 k € | +70.1% | -185 k € | -10.0% | -168,1 k € | -179% | 211,8 k € | +343% | 47,8 k € |
| Operating result | -60,2 k € | +68.2% | -189,5 k € | -25.9% | -150,5 k € | -181% | 185,9 k € | +290% | 47,7 k € |
| Net result | 2,9 M € | +1110% | -284,4 k € | -106% | 5 M € | +311% | 1,2 M € | +136% | -3,4 M € |
| Balance sheet | |||||||||
| Equity | 53,4 M € | +5.7% | 50,5 M € | +2.7% | 49,2 M € | +11.2% | 44,3 M € | +2.8% | 43,1 M € |
| Total assets | 67,4 M € | +12.8% | 59,8 M € | +1.2% | 59,1 M € | +10.1% | 53,6 M € | +4.1% | 51,5 M € |
| Cash | 19,6 k € | -60.6% | 49,8 k € | -98.7% | 3,8 M € | +1704% | 209,4 k € | +6.7% | 196,2 k € |
| Debts | 14 M € | +51.7% | 9,3 M € | -6.1% | 9,9 M € | +5.1% | 9,4 M € | +10.6% | 8,5 M € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 25 ended
Active mandates
Ended mandates
Other companies at this address
Boulevard Bischoffsheim 39 1000 Bruxelles| Company | CBE no. |
|---|---|
A1 Services● Active | 1002.005.743 |
AAZ● Active | 1001.904.090 |
ABDS● Active | 0734.979.985 |
Accola● Active | 0743.729.979 |
ACCOUNT & CIE● Active | 0777.708.683 |
ACIA CONSULT● Active | 1011.765.329 |
ACIA Group● Active | 0890.634.697 |
ACII● Active | 0655.909.248 |
ACORD MED SPRL● Active | 0671.452.311 |
AD Algorithms● Active | 1020.620.043 |
ADC GARDEN● Active | 0773.363.974 |
ADNEY● Active | 0669.744.121 |
ADVENTOR● Active | 1010.234.313 |
A-E ACHATS● Active | 0779.483.189 |
AEM Consult● Active | 0767.519.131 |
Aever Clinics Belgium● Active | 1042.027.448 |
AEXIS GROUP● Active | 0644.747.419 |
AFRISOURCE● Active | 1015.442.817 |
AFROPEAN CUISINE● Active | 0687.849.566 |
AFTERCUBE● Active | 0899.522.273 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 03/08/2026 | 16/07/2025 | 02/07/2024 | 08/11/2023 | 01/12/2022 | 10/06/2021 |
| General meeting | 19/06/2026 | 20/06/2025 | 20/06/2024 | 27/09/2023 | 24/06/2022 | 12/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 22 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 19/06/2026 | 03/08/2026 | French | |
| Full model | 31/12/2024 | 20/06/2025 | 16/07/2025 | French | |
| Full model | 31/12/2023 | 20/06/2024 | 02/07/2024 | French | |
| Full modelCorrection | 31/12/2022 | 27/09/2023 | 08/11/2023 | French | |
| Full model | 31/12/2022 | 20/06/2023 | 21/08/2023 | French | |
| Full model | 31/12/2021 | 24/06/2022 | 01/12/2022 | French | |
| Full model | 31/12/2020 | 12/05/2021 | 10/06/2021 | French | |
| Full model | 31/12/2019 | 08/07/2020 | 14/08/2020 | French | |
| Full model | 31/12/2018 | 08/05/2019 | 21/06/2019 | French | |
| Full model | 31/12/2017 | 13/06/2018 | 13/08/2018 | French | |
| Full modelCorrection | 31/12/2016 | 30/06/2017 | 13/12/2017 | French | |
| Full model | 31/12/2016 | 30/06/2017 | 24/08/2017 | French | |
| Full model | 31/12/2015 | 15/06/2016 | 15/06/2016 | French | |
| Full model | 31/12/2014 | 26/05/2015 | 11/06/2015 | French | |
| Full model | 31/12/2013 | 03/06/2014 | 11/07/2014 | French | |
| Full model | 31/12/2012 | 21/06/2013 | 12/07/2013 | French | |
| Full model | 31/12/2011 | 09/05/2012 | 28/06/2012 | French | |
| Full model | 31/12/2010 | 11/05/2011 | 28/06/2011 | French | |
| Full model | 31/12/2009 | 12/05/2010 | 11/08/2010 | French | |
| Full model | 31/12/2008 | 13/05/2009 | 30/06/2009 | French | |
| Full model | 31/12/2007 | 14/05/2008 | 24/06/2008 | French | |
| Full model | 31/12/2006 | 09/05/2007 | 26/06/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 50 M€ and 100 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 25 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates10/10/2024DEMISSIONS, NOMINATIONS
- Restructuring26/07/2024CAPITAL, ACTIONS - ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring24/05/2024RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
- Mandates29/11/2023DEMISSIONS, NOMINATIONS
- Mandates23/02/2023DEMISSIONS, NOMINATIONS
- Mandates07/09/2022DEMISSIONS, NOMINATIONS
- Registered office23/09/2021SIEGE SOCIAL
- Mandates25/06/2021DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20252,9 M €↑
- 2024Annual accounts 2024-284,4 k €↓
- 2023Annual accounts 20235 M €↑
- 06/09/2023nominationGuillaume Taillandier — administrateur
- 31/12/2022nominationMichaël Focant — représentant permanent du commissaire KPMG
- 2022Annual accounts 20221,2 M €↑
- 24/06/2022reconductionXavier Defourt — administrateur
- 24/06/2022reconductionRenaud Dehareng — administrateur
- 2021Annual accounts 2021-3,4 M €↓
- 11/10/2021nominationXavier Nys — représentant permanent du commissaire KPMG
- 2020Annual accounts 20204,6 M €↓
- 2019Annual accounts 201911,3 M €↑
- 2018Annual accounts 2018637,6 k €↑
- 2018Name changeCurium International
- 2017Annual accounts 2017511,9 k €↓
- 2016Annual accounts 2016181,2 M €↑
- 2015Annual accounts 2015-8,9 M €↓
- 2014Annual accounts 2014-1,5 M €↓
- 2013Annual accounts 20131,6 M €↑
- 2012Annual accounts 2012-32,8 M €↑
- 2011Annual accounts 2011-51,3 M €↓
- 2010Annual accounts 2010-5,8 M €↑
- 2009Annual accounts 2009-15,5 M €↓
- 2008Annual accounts 2008-1,3 M €
- 2008Name changeIBA Pharma
- 22/08/2003IncorporationPublic limited company